Terumo Corporation (TRUMF)
- Previous Close
20.05 - Open
19.40 - Bid 17.73 x 38800
- Ask 20.00 x 40000
- Day's Range
19.40 - 19.40 - 52 Week Range
12.65 - 20.83 - Volume
133 - Avg. Volume
5,690 - Market Cap (intraday)
30.712B - Beta (5Y Monthly) 0.45
- PE Ratio (TTM)
36.60 - EPS (TTM)
0.53 - Earnings Date Nov 7, 2024
- Forward Dividend & Yield 0.17 (0.95%)
- Ex-Dividend Date Mar 28, 2025
- 1y Target Est
--
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.
www.terumo.comRecent News: TRUMF
View MorePerformance Overview: TRUMF
Trailing total returns as of 10/17/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TRUMF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TRUMF
View MoreValuation Measures
Market Cap
29.17B
Enterprise Value
29.18B
Trailing P/E
34.71
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.27
Price/Book (mrq)
3.07
Enterprise Value/Revenue
4.49
Enterprise Value/EBITDA
18.10
Financial Highlights
Profitability and Income Statement
Profit Margin
12.20%
Return on Assets (ttm)
5.49%
Return on Equity (ttm)
8.98%
Revenue (ttm)
964.81B
Net Income Avi to Common (ttm)
117.72B
Diluted EPS (ttm)
0.53
Balance Sheet and Cash Flow
Total Cash (mrq)
194.91B
Total Debt/Equity (mrq)
16.54%
Levered Free Cash Flow (ttm)
66.25B
Company Insights: TRUMF
TRUMF does not have Company Insights